Which funds are similar to ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth?
Funds similar to ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth in the Equity: Sectoral-Pharma category are listed in the Similar Funds tab, selected based on same category and benchmark index.
How does ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth compare to the category average?
The comparison of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth against the Equity: Sectoral-Pharma category average — returns, alpha, beta and Sharpe — is shown in the Category vs Scheme Returns section at the top of the Similar Funds tab.
What is the rank of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth in its category?
The rank of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth within the Equity: Sectoral-Pharma category is shown in the Trailing Returns section on the Performance tab and the Similar Funds tab.
What are the alternatives to ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth?
Top alternatives to ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth in the Equity: Sectoral-Pharma category, sorted by AUM, are listed in the Similar Funds tab. Funds tracking the same benchmark — BSE Healthcare Total Return Index — are also listed separately.
How does ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth's expense ratio compare to similar funds?
The expense ratio of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth is 1.33%. Over a 20-year investment, a 0.5% difference in expense ratio on a ₹10 lakh corpus can amount to lakhs in additional wealth creation.
How does ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth's AUM compare to similar funds?
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth has an AUM of ₹ 6.45 k Cr. AUM reflects investor confidence. For small cap funds, very large AUM can limit portfolio flexibility.
Which fund has the best 3-year returns in the Equity: Sectoral-Pharma category?
The top-performing funds by 3-year returns in the Equity: Sectoral-Pharma category can be found by sorting the Similar Funds comparison table by the 3Y column.
Is ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth better than index funds in the same category?
Whether ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth beats index funds in the Equity: Sectoral-Pharma category can be assessed by comparing its trailing returns against the benchmark returns in the Performance tab. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth has an alpha of 2.11%, indicating active outperformance over the benchmark. Historically, active funds in India have shown mixed results vs index funds — large cap active funds tend to underperform index funds over 10 years, while mid/small cap active managers have often added alpha.
How does ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth rank in risk-adjusted returns vs peers?
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth has a Sharpe ratio of 1.17 and alpha of 2.11%. A Sharpe of 1.17 means the fund generates strong returns per unit of risk. Risk-adjusted comparison across category peers — Sharpe, alpha and beta — is shown in the Alpha, Beta & Sharpe section of the Performance tab.
Are there any funds tracking BSE Healthcare Total Return Index with lower costs?
Funds tracking the same benchmark as ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth — BSE Healthcare Total Return Index — are listed in the Similar Funds tab. Compare their expense ratios to find the most cost-efficient option for the same index exposure.
